- Home
- Products
- Customized FluoroAb™
- FXYD5
- Anti-FXYD5 MAb (Clone 1)-iFluor® 405 Succinimidyl Ester
Anti-FXYD5 MAb (Clone 1)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS1813)
This product is comprised of an Human Anti-FXYD5 antibody (Clone 1) labeled with iFluor® 405 Succinimidyl Ester. iFluor® 405 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- FXYD5
- Alternative Names
- FXYD5; DYSAD; IWU1; KCT1; OIT2; PRO6241; RIC; HSPC113; FXYD domain containing ion transport regulator 5
- Overview
- Human Anti-FXYD5 antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 405 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 403/427
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-DLL4 Therapeutic Antibody-iFluor 488 (CAT#: ADC-FL-1101)
- Anti-C-kit MAb (Clone 1)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS7957)
- Anti-CTLA4 MAb (Clone 5)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5851)
- Anti-KDR MAb (Clone 7)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7168)
- Anti-FLT1 MAb (Clone 1)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15600)
- Anti-PCSK9 MAb (Clone 3)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9993)
- Clenoliximab-PBlue (CAT#: ADC-FL-702)
- Anti-MUC1 MAb (Clone 2)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS347)
- Farletuzumab-iFluor 350 (CAT#: ADC-FL-1531)
- Anti-Phosphatidylserine MAb (Clone 1)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3800)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS1813. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-079 | Anti-FXYD5-PEG-cardiac glycoside ADC | PEG (polyethylene glycol) | cardiac glycoside |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.